×
0.0791666666666666 0.0791666666666666 0.0791666666666666 0.0525833333333335 0.0525833333333335 0.0625000000000002 0.0833333333333334 0.0833333333333334
Stockreport

ContraFect to Present New Clinical and Microbiological Data on CF-301 at ASM Microbe 2017

CONTRAFECT CORP COMMON (CFRX)  More Company Research Source: Marketwire
US:NASDAQ Investor Relations: ir.contrafect.com
PDF YONKERS, NY -- (Marketwired) -- 06/01/17 -- ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announces five poster presentations of new data from the CF-301 development program at the American Society for Microbiology (ASM) Microbe 2017 conference to be held on June 1-5, 2017 in New Orleans, LA. ContraFect's lead compound, CF-301 is the first member of the lysin class to enter Phase 2 of clinical development in the US for the treatment of Staphylococcus aureus (Staph aureus) bacteremia including endocarditis. Initial data from the Phase 1, first-in-human study of CF-301 in healthy volunteers, presented in 2016, demonstrated CF-301 to be well-tolerated with no clinical adverse safety signals. New analyses of clinical data from this Phase 1 trial which further support the safety profile of C [Read more]

IMPACT SNAPSHOT EVENT TIME: CFRX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS